PLoS ONE (Jan 2017)

Etiology and mode of presentation of chronic liver diseases in India: A multi centric study.

  • Partha S Mukherjee,
  • Sreenivas Vishnubhatla,
  • Deepak N Amarapurkar,
  • Kausik Das,
  • Ajit Sood,
  • Yogesh K Chawla,
  • Chundamannil E Eapen,
  • Prabhakar Boddu,
  • Varghese Thomas,
  • Subodh Varshney,
  • Diamond Sharma Hidangmayum,
  • Pradip Bhaumik,
  • Bhaskar Thakur,
  • Subrat K Acharya,
  • Abhijit Chowdhury

DOI
https://doi.org/10.1371/journal.pone.0187033
Journal volume & issue
Vol. 12, no. 10
p. e0187033

Abstract

Read online

There is a paucity of health policy relevant data for chronic liver disease from India, impeding formulation of an interventional strategy to address the issue. A prospective, multicentric study to delineate the etiology and clinical profile of chronic liver disease in India is reported here. A centrally coordinated and monitored web-based data repository was developed (Feb, 2010 to Jan, 2013) and analyzed. Eleven hospitals from different parts of India participated. Data were uploaded into a web based proforma and monitored by a single centre according to a standardized protocol. 1.28% (n = 266621) of all patients (n = 20701383) attending the eleven participating hospitals of India had liver disease. 65807 (24·68%) were diagnosed for the first time (new cases). Of these, 13014 (19·77%, median age 43 years, 73% males) cases of chronic liver disease were finally analyzed. 33.9% presented with decompensated cirrhosis. Alcoholism (34·3% of 4413) was the commonest cause of cirrhosis while Hepatitis B (33·3%) was predominant cause of chronic liver disease in general and non-cirrhotic chronic liver disease (40·8% out of 8163). There was significant interregional differences (hepatitis C in North, hepatitis B in East and South, alcohol in North-east, Non-alcoholic Fatty Liver Disease in West) in the predominant cause of chronic liver disease. Hepatitis B (46·8% of 438 cases) was the commonest cause of hepatocellular Cancer.11·7% had diabetes. Observations of our study will help guide a contextually relevant liver care policy for India and could serve as a framework for similar endeavor in other developing countries as well.